KraneShares MSCI All China Health Care Index ETF (KURE) Dividend Yield, History & Forecast

KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund (ETF) listed on the New York Stock Exchange Arca. It pays a current dividend yield of 4.12% ($0.71 per share annually (TTM)). The most recent ex-dividend date was December 22, 2025, with payment scheduled for December 23, 2025. market capitalization is approximately $99M.

KURE fund composition

KURE holds 53 positions, with 54.6% of assets in its ten largest. It charges an expense ratio of 0.79%, and manages $100.8M.

Top 10 holdings

HoldingWeight
6160.HKBEONE MEDICINES LTD-H9.07%
1801.HKINNOVENT BIOLOGICS INC8.46%
2269.HKWUXI BIOLOGICS CAYMAN INC7.98%
603259.SSWUXI APPTEC CO LTD-A5.95%
300760.SZSHENZHEN MINDRAY BIO-MEDIC-A4.40%
600276.SSJIANGSU HENGRUI PHARMACEUT-A4.26%
9926.HKAKESO INC3.75%
1093.HKCSPC PHARMACEUTICAL GROUP LT3.72%
2359.HKWUXI APPTEC CO LTD-H3.57%
1177.HKSINO BIOPHARMACEUTICAL3.46%

Sector allocation

Healthcare99.3%Consumer Defensive0.7%

Frequently Asked Questions about KraneShares MSCI All China Health Care Index ETF (KURE)

What is KraneShares MSCI All China Health Care Index ETF's dividend yield?
KraneShares MSCI All China Health Care Index ETF (KURE) pays a current trailing twelve-month dividend yield of 4.12%, which works out to $0.71 per share annually based on the most recent payout schedule.
When does KraneShares MSCI All China Health Care Index ETF pay distributions?
The most recent ex-dividend date was December 22, 2025. The next scheduled dividend payment date is December 23, 2025.
How many years has KraneShares MSCI All China Health Care Index ETF increased its dividend?
KraneShares MSCI All China Health Care Index ETF (KURE) has increased its dividend for 3 consecutive years.
What does KraneShares MSCI All China Health Care Index ETF invest in?
This exchange-traded fund will allocate at least 80% of its net assets, including any capital acquired through borrowing for investment purposes, to financial instruments that are components of its underlying index or exhibit similar economic characteristics. The reference index is a market capitalization-weighted measure, adjusted for free float, and applies a 10/40 Constraint. Its objective is to gauge the equity market performance of Chinese enterprises within the healthcare sector. This fund does not maintain a diversified portfolio.